Differential effect of inhibitory strategies of the V617 mutant of JAK2 on cytokine receptor signaling

This publication has 50 references indexed in Scilit:

• Crystal structures of the JAK2 pseudokinase domain and the pathogenic mutant V617F
  Nature Structural & Molecular Biology, 2012
• Mutation that blocks ATP binding creates a pseudokinase stabilizing the scaffolding function of kinase suppressor of Ras, CRAF and BRAF
  Proceedings of the National Academy of Sciences, 2011
• The Constitutive Activation of Jak2-V617F Is Mediated by a π Stacking Mechanism Involving Phenylalanines 595 and 617
  Biochemistry, 2010
• Targeting Bcr–Abl by combining allosteric with ATP-binding-site inhibitors
  Nature, 2010
• JAK mutations in high-risk childhood acute lymphoblastic leukemia
  Proceedings of the National Academy of Sciences, 2009
• Ligand-independent Homomeric and Heteromeric Complexes between Interleukin-2 or -9 Receptor Subunits and the γ Chain
  Journal of Biological Chemistry, 2008
• Somatically acquired JAK1 mutations in adult acute lymphoblastic leukemia
  Journal of Experimental Medicine, 2008
• JAK2Exon 12 Mutations in Polycythemia Vera and Idiopathic Erythrocytosis
  New England Journal of Medicine, 2007
• JAK2T875N is a novel activating mutation that results in myeloproliferative disease with features of megakaryoblastic leukemia in a murine bone marrow transplantation model
  Blood, 2006
• A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera
  Nature, 2005